Company: XAIR
Filing Date: 2025-11-10
Form Type: 10-Q
Source: 0001493152-25-021561
Chunk: 63

Company: Beyond Air, Inc.
Filing Date: 2025-11-10
Form: 10-Q
Item: Part I, Item 1
Chunk 63
---
in thousands) 
    2025  
    2024 

    Net cash provided by (used in): 

    Operating activities 
    $(8,979) 
    $(23,528)
  
    Investing activities 
     816  
     19,261 
  
    Financing activities 
     12,984  
     21,360 
  
    Effect of exchange rate changes on cash and cash equivalents 
     145  
     (23)
  
    Net increase (decrease) in cash, cash equivalents and restricted cash 
    $4,966  
    $(17,069)

Operating
Activities

For
the six months ended September 30, 2025 the net cash used in operating activities was $9.0 million which was primarily due to our net
loss of $16.3 million, which includes $3.4 million of stock-based compensation, $1.6 million of depreciation and amortization, and $1.0
million of paid in kind interest and amortization of debt discount associated with the Loan Agreement, in addition to $0.9 million in
prepayments and other assets.

For
the six months ended September 30, 2024 the net cash used in operating activities was $23.5 million which was primarily due to our net
loss of $27.1 million, which includes $6.6 million of stock-based compensation, $0.4 million received in grant payments, $1.5 million
of depreciation and amortization, $3.9 million of accrued expenses (which included ($4.5) million of the payment of the final tranche
of the Circassia settlement and ($2.9) million for the Hudson Bay settlement and ($7.6) million attributable to the resolution of Empery
Asset Master, Ltd. Et AL, vs AIT Therapeutics Inc.)

Investing
Activities

For
the six months ended September 30, 2025, net cash provided by investing activities was $0.8 million which was mainly attributable to
a net redemption of investments in marketable securities of $1.3 million and invested $0.4 million for the purchase of property and equipment,
mainly LungFit PH devices.

For
the six months ended September 30, 2024, net cash provided by investing activities was $19.3 million which was mainly attributable to
a net redemption of investments in marketable securities of $23.1 million and